“Your rotator cuff tear is too large to repair.”
For the golfers at Westlake Golf Course, the pickleball players at Rancho Conejo Playfields, the firefighters and tradespeople from Simi Valley and Thousand Oaks — those six words can feel like a door closing on an active life. They may have been delivered matter-of-factly by a surgeon who didn’t offer much beyond them. They may have prompted a frantic Google search that led here.
Here is what I tell every patient who comes to my Thousand Oaks or Simi Valley office after hearing that their tear is too large to repair: that sentence is often incomplete — and sometimes it’s wrong.
Whether a rotator cuff tear is “too large to repair” depends on specific anatomic variables that require fellowship-trained assessment of the raw MRI images — not just a radiology report, not a 10-minute consultation with a general orthopedic surgeon. And even when a tear is genuinely irreparable, the treatment options available in 2025 extend far beyond “we can’t fix it” — from biologic patch augmentation and superior capsular reconstruction to subacromial balloon spacers, tendon transfers, and the carefully selected use of reverse shoulder replacement.
This post explains all of it.
What Makes a Rotator Cuff Tear “Irreparable”?
The term “irreparable” does not mean the tendon cannot be reattached to bone. It means that the tendon — after reattachment — is unlikely to heal in a way that restores meaningful function. Several anatomic variables determine this, and each must be assessed on the raw DICOM MRI images, not the radiology summary.
1. Tear Size
Tears are classified by size: small (<1 cm), medium (1–3 cm), large (3–5 cm), and massive (>5 cm, or involving 3 or more tendons). Massive tears are the primary category associated with potential irreparability, but tear size alone does not determine repairability — it is one factor among several.
2. Tendon Retraction
When a tendon tears, it retracts — the free end pulls back from its footprint on the humeral head. Minor retraction (Stage 1 — to the humeral head) is manageable. Severe retraction (Stage 3 — to the glenoid level or beyond) makes primary repair mechanically impossible without placing the tendon under tension that will inevitably fail.
3. Fatty Infiltration and Muscle Atrophy — The Goutallier Grade
This is the most underappreciated variable in rotator cuff tear assessment — and the one that most surgeons fail to explain to patients. When a tendon tears and retracts, the associated muscle belly undergoes fatty infiltration over time — fat gradually replaces functional muscle tissue. This is graded on MRI using the Goutallier classification (Grade 0–4). Grade 0–1 muscle is healthy and responds well to repair. Grade 3–4 muscle — more than 50% replaced by fat — is irreversible. A repair performed on Grade 3–4 muscle will fail regardless of surgical technique, because the muscle can no longer generate meaningful force even with the tendon reattached.
This is why timing matters so critically. A Grade 0–1 tear repaired today heals reliably. The same tear, left untreated for 18 months, may progress to Grade 3–4 — at which point the biological and mechanical conditions for repair no longer exist.
4. Tissue Quality at the Torn Edge
A tendon that has been torn for years undergoes degenerative changes at the free edge — the tissue becomes friable, thin, and unable to hold sutures reliably. Even if a tear is not severely retracted and the muscle grade is acceptable, poor tissue quality at the torn edge can doom a repair.
5. Number of Tendons Involved
Isolated supraspinatus tears are far more reliably repairable than tears involving both the supraspinatus and infraspinatus, or all three posterior cuff tendons, or tears that also involve the subscapularis anteriorly. Multi-tendon involvement changes the biomechanical loading across the repair and significantly affects healing probability.
Option 1: Primary Repair — With Biologic Patch Augmentation
Before any discussion of irreparable tear management, it is worth understanding that many tears told to patients as “too large to repair” are, in fact, repairable — with the right technique. And even for tears that are genuinely at high risk of re-tear after primary repair, the addition of biologic patch augmentation has emerged as one of the most evidence-supported advances in rotator cuff surgery over the past five years.
The Re-Tear Problem
Rotator cuff re-tear after arthroscopic repair is one of the most significant challenges in shoulder surgery. The literature reports re-tear rates ranging from 20% to 94% for large and massive tears — a wide range that reflects the enormous variability in patient selection, tear characteristics, and tissue quality. The patients at highest risk are those with large tears, Grade 2+ fatty infiltration, significant tendon retraction, older age, diabetes, smoking history, and poor tissue quality.
What Is Biologic Patch Augmentation?
Biologic patch augmentation involves placing a biological scaffold — most commonly an acellular dermal allograft (ADM) — over the primary rotator cuff repair to mechanically reinforce it, provide a biological scaffold for healing, and protect the repaired tendon during the vulnerable early healing phase. The graft is secured to the repaired tendon and the surrounding tissue arthroscopically, without requiring additional incisions.
The two most commonly used types are:
- Acellular human dermal allograft (ADM) — derived from processed human dermis with all cellular components removed, leaving a collagen scaffold that supports ingrowth of native tissue. The ArthroFLEX graft is the most studied proprietary product in this category.
- Bioinductive collagen patch (Smith+Nephew Regeneten) — a bovine-derived collagen scaffold that stimulates new tendon tissue formation rather than simply bridging a defect. The bioinductive mechanism is distinct from structural augmentation and targets partial tears as well as full-thickness repairs.
What the Evidence Shows
The evidence for biologic patch augmentation in high-risk rotator cuff repairs is among the strongest in the current shoulder surgery literature:
- A 2025 systematic review and meta-analysis published in Arthroscopy covering 24 studies including 12 randomized controlled trials concluded that structural augmentation significantly reduced the risk of re-tear in patients with full-thickness rotator cuff tears, across both biologic allograft and synthetic augment types
- A landmark prospective study with ArthroFLEX found retear rates of 10% in the augmented group versus 26% in the non-augmented control group (p=0.024), with significantly better ASES functional scores at 24 months
- A 2025 Arthroscopy study (Kim et al.) using the Rotator Cuff Healing Index (RoHI) found that in high-risk patients (RoHI ≥7), ADM patch augmentation effectively reduced re-tear rates regardless of sex or other demographic factors
- A meta-analysis of the bioinductive Regeneten patch published in Journal of Shoulder and Elbow Surgery found an overall re-tear rate of just 8.3% for full-thickness repairs augmented with the bioinductive patch — compared to historical rates of 40–94% for large unaugmented repairs
- A 2024 review in PMC confirmed that biologic augmentation reduces re-tear rates ranging from 17% to 45% for large tears, with the best outcomes in patients identified as high-risk on pre-operative scoring
A Note on Volume and Expertise in Biologic Patch Augmentation
Biologic patch augmentation is not a procedure offered at most orthopedic practices in Ventura County. It requires specific arthroscopic expertise — precise graft preparation, secure fixation at the repair interface, and intraoperative judgment about when augmentation will add meaningful value versus when primary repair alone is sufficient. I am one of the very few surgeons in the Conejo Valley and greater Ventura County region performing biologic patch augmentation at meaningful volume — and among the handful in Southern California whose case volume in this procedure meets the threshold that the outcomes literature consistently associates with superior results.
For active patients from Thousand Oaks, Simi Valley, Westlake Village, Moorpark, and Camarillo who have been told their tear has a high risk of re-tear — or who have had a prior repair that failed — biologic patch augmentation may meaningfully change the probability of a durable outcome. This is a conversation worth having at a consultation before accepting a “too large to repair” verdict or proceeding with conventional repair alone.

Large & Massive Rotator Cuff Tear: All Surgical Options Compared
For patients in Thousand Oaks, Simi Valley & Ventura County — from biologic patch augmentation to reverse shoulder replacement
| CATEGORY | Primary Repair + Patch Augmentation | Superior Capsular Reconstruction | InSpace Balloon Spacer | Tendon Transfer (LTTT / Lat Dorsi) | Reverse TSA |
|---|---|---|---|---|---|
| Best Candidates | Repairable tear with high re-tear risk; Grade 0–2 muscle; prior failed repair needing revision | Irreparable posterosuperior tear; younger active patient; preserved cartilage; intact subscapularis | Older (70s–80s), lower-demand; preserved active ROM; primary goal is pain relief | Younger (<65), high-demand; irreparable posterosuperior tear; preserved cartilage; intact subscapularis | Cuff tear arthropathy; Grade 3–4 fatty infiltration; glenohumeral arthritis; older patients |
| Goutallier Grade | Grade 0–2 — muscle still functional | Grade 2–3 — some atrophy acceptable | Grade 2–4 — muscle quality less critical | Grade 2–3 — transferred muscle must be intact | Grade 3–4 — repair not viable |
| Cartilage Requirement | Cartilage preserved (repair procedure) | Must be preserved — not for arthropathy | Best without significant cartilage loss | Must be preserved — not for arthropathy | Designed for cartilage loss / arthropathy |
| Re-Tear / Failure Rate | Patch reduces retear to 8–10% (vs 40–94% unaugmented large tears) | Graft failure reported in some series; patient selection critical | Balloon degrades at ~12 months; long-term function depends on remaining muscles | Durable when successful; technical complexity is the main variable | 88% survivorship at 10 years — JBJS Open Access 2025 |
| Return to Golf | 73–91% — comparable to standard repair | High for appropriately selected patients | Depends on remaining muscle function; less predictable | Good external rotation restoration supports golf mechanics | 88.9% — ASES multicenter 2026 |
| Sling / Recovery | Sling 4–6 wks; full activity 9–12 mo | Sling 4–6 wks; full activity 9–12 mo | Minimal immobilization; fastest recovery | Sling 6+ wks; longer rehabilitation; full activity 12+ mo | Sling 4–6 wks; full sport 5–12 mo |
| Available in Ventura County | Yes — Dr. Sivasundaram, Thousand Oaks & Simi Valley (high-volume) | Yes — Dr. Sivasundaram, Thousand Oaks & Simi Valley | Yes — Dr. Sivasundaram, Thousand Oaks & Simi Valley | Yes — Dr. Sivasundaram, Thousand Oaks & Simi Valley | Yes — Mako robotic-assisted, Thousand Oaks & Simi Valley |
| Evidence Level | Strong — 24-study meta-analysis incl. 12 RCTs (2025) | Moderate — systematic reviews, Level III–IV | Moderate — Level I RCT (SPACE trial); conflicting results | Emerging — comparative studies; growing evidence base | Strongest — multiple systematic reviews, Level I–II |
Dr. Sivasundaram’s Note — Why This Decision Requires Expert Assessment
The right procedure from this table is determined by a combination of variables that only emerge from personal review of your MRI images: Goutallier grade of each tendon, retraction stage, cartilage status, subscapularis integrity, and tissue quality at the torn edge. I am one of the very few surgeons in Ventura County performing the full spectrum of these procedures at meaningful volume — including biologic patch augmentation, SCR, and tendon transfer, in addition to Mako robotic-assisted reverse shoulder replacement. If you’ve been told your tear is irreparable, call us at (805) 379-4574 (Thousand Oaks) or (805) 527-1404 (Simi Valley) and bring your MRI disc.
When the Tear Is Truly Irreparable: Advanced Surgical Options
For a subset of patients — typically those with Grade 3–4 fatty infiltration, severe retraction to the glenoid level, or multi-tendon involvement with poor tissue quality — primary repair, even with patch augmentation, is not the right answer. In these cases, a different set of surgical tools exists. The choice among them depends on the patient’s age, functional demands, rotator cuff status beyond the tear, and whether glenohumeral arthritis is present.
Option 2: Superior Capsular Reconstruction (SCR)
Superior capsular reconstruction was developed by Japanese surgeon Hiroaki Minami Teruhisa Mihata in 2012 and has become one of the most important advances in irreparable rotator cuff tear management of the past decade. The concept: when the supraspinatus (and sometimes infraspinatus) is irreparable, the superior capsule of the shoulder — which normally contributes to superior stability — is reconstructed using a graft to restore the mechanical stability of the humeral head within the socket.
How it works: A graft — most commonly a dermal allograft or the long head of the biceps tendon (LHBT) — is fixed to the superior glenoid on one end and the greater tuberosity on the other, effectively creating a new superior restraint that prevents the humeral head from migrating upward into the acromion. This restores the force couple balance of the shoulder and allows the deltoid to produce meaningful arm elevation without the supraspinatus.
What the evidence shows:
- A systematic review published in Arthroscopy confirmed that arthroscopic SCR produces statistically and clinically significant improvements in patient-reported outcomes and range of motion with low graft failure, complication, and reoperation rates at short-term follow-up
- A 2024 meta-analysis published in Journal of Clinical Medicine (Shin, Jang, Han) covering 456 cases across 6 studies found that SCR using the long head of the biceps tendon significantly reduced re-tear rates compared to conventional rotator cuff repair in large to massive tears (OR = 0.21; p < 0.01) — meaning the odds of re-tear were reduced by approximately 80%
- Acromiohumeral interval — the space between the humeral head and acromion that narrows in cuff tear arthropathy — was significantly improved after SCR compared to conventional repair
Best candidates: Patients with massive irreparable posterosuperior cuff tears (supraspinatus ± infraspinatus) who have relatively preserved glenohumeral cartilage, active deltoid function, and are not yet ready for shoulder replacement. Typically younger, higher-demand patients — the golfer at Los Robles Greens or Westlake Golf Course in their late 50s who wants to avoid replacement for another decade.
Limitations: SCR does not address glenohumeral arthritis. In patients with significant cartilage loss, the procedure may provide limited benefit. A 2024 editorial in Arthroscopy (Provencher et al.) noted that while early results are promising, high rates of complications including graft retear and incomplete healing have been reported in some series — emphasizing that patient selection and surgeon technique are critical determinants of outcome.
Option 3: Subacromial Balloon Spacer (InSpace)
The InSpace biodegradable subacromial balloon spacer — FDA-cleared in the United States in 2021 — represents a less invasive option for a specific subset of irreparable cuff tear patients. The device is a biodegradable balloon implanted arthroscopically into the subacromial space, where it physically separates the humeral head from the acromion, reducing mechanical impingement and allowing the deltoid and remaining cuff muscles to function more effectively.
How it works: The balloon is filled with saline and remains in place for approximately 12 months before gradually biodegrading. During this window, it acts as a spacer that centralized the humeral head in the glenoid, reducing superior migration, decreasing friction, and allowing a pain-free arc of motion that the native mechanics could no longer produce. It does not reconstruct or replace the missing tendon — it mechanically compensates for its absence.
What the evidence shows:
- A 2024 systematic review and meta-analysis in Knee Surgery, Sports Traumatology, Arthroscopy (Sirignano et al.) covering 27 studies and 894 patients found significant improvements in Constant-Murley scores (34.8 → 64.2 at 12 months) and ASES scores (35.1 → 83.3 at 12 months)
- A 2025 study in Arthroscopy confirmed excellent long-term outcomes and high revision-free survival rates at minimum 5-year follow-up
- The landmark SPACE trial — a Level I, non-inferiority RCT in the United States — found InSpace non-inferior to partial rotator cuff repair, with over 80% of patients in both groups meeting MCID thresholds for ASES scores, and active forward elevation favoring InSpace at multiple timepoints
- A separate Level I UK RCT (START:REACTS, Lancet 2022) found less favorable results, contributing to ongoing controversy about the device’s role and optimal patient selection
Best candidates: Older (70s–80s), lower-demand patients with preserved active range of motion and an irreparable posterosuperior tear who prioritize a fast, minimally invasive procedure with minimal immobilization. The InSpace is not the right choice for patients whose primary complaint is weakness rather than pain, or for those with pseudoparalysis (inability to actively elevate the arm).
Key advantage: Rapid recovery — most patients resume light activity within days and have minimal immobilization requirements compared to SCR or tendon transfer.
Option 4: Tendon Transfer (Lower Trapezius or Latissimus Dorsi)
For younger, higher-demand patients with irreparable posterosuperior cuff tears who are not yet candidates for shoulder replacement, tendon transfer represents a reconstructive option that provides durable, active function by rerouting a functioning muscle-tendon unit to replace the irreparably torn one.
Lower Trapezius Tendon Transfer (LTTT): The most recently described and increasingly favored option for irreparable posterosuperior tears. The lower trapezius — which functions as an external rotator of the scapula — is transferred (often augmented with an Achilles tendon allograft) to the posterior greater tuberosity, where it biomechanically reproduces the function of the irreparable infraspinatus. A 2025 comparative study in Journal of Shoulder and Elbow Surgery (McKissack, Cooke et al.) directly compared arthroscopic-assisted LTTT versus SCR for irreparable massive cuff tears and found comparable clinical outcomes, with the LTTT providing superior external rotation strength restoration.
Latissimus Dorsi Transfer: The historically more commonly performed tendon transfer for irreparable posterosuperior tears. The latissimus dorsi is transferred anteriorly and superiorly to the greater tuberosity. It provides meaningful restoration of elevation and external rotation, though outcomes are most predictable in the absence of subscapularis pathology and pseudoparalysis.
Best candidates: Younger, active patients (typically under 65) with irreparable posterosuperior tears, preserved glenohumeral cartilage, intact subscapularis, and high functional demands. The golfer who needs full external rotation for a consistent swing; the Ventura County firefighter who needs full shoulder function for occupational demands. Tendon transfer is more technically demanding and carries a longer recovery than SCR or balloon spacer — but for the right patient, it provides the most durable active function restoration of any joint-preserving option.
Option 5: Biologic Tuberoplasty
Biologic tuberoplasty — also called biological resurfacing or humeral head resurfacing — is a less commonly discussed but valuable option for a specific subset of patients: those with massive irreparable tears accompanied by cuff tear arthropathy of the humeral head but without significant glenoid involvement. The procedure involves smoothing and reshaping the eroded surface of the greater tuberosity and humeral head, followed by biological coverage with a dermal allograft patch to reduce friction and pain from impingement against the acromion.
The concept is not to restore rotator cuff function — which is not possible — but to create a more favorable biomechanical environment for the shoulder to function with the muscles it still has. It is sometimes combined with subacromial decompression and biceps tenodesis. Outcomes data is still accumulating, and current evidence places it primarily as a salvage option for elderly, lower-demand patients who are poor candidates for more complex reconstruction but whose joint status does not yet warrant replacement.
Option 6: Reverse Total Shoulder Replacement
For patients with cuff tear arthropathy — the end-stage condition where a massive, long-standing cuff tear has led to humeral head migration and glenohumeral cartilage destruction — reverse total shoulder arthroplasty is the definitive, most evidence-supported surgical solution. By reversing the ball-and-socket geometry of the joint, rTSA allows the deltoid to power arm elevation without requiring a functional rotator cuff. It carries the largest volume of high-quality outcomes literature of any option discussed in this post.
The 2025 McMaster systematic review (3,092 patients) confirmed an 85.1% return-to-sport rate. The 2026 ASES multicenter study found an 88.9% return-to-golf rate. The 2025 Denard study found a 100% return-to-pickleball rate. For Conejo Valley patients whose tear has progressed to the point where joint-preserving options are no longer viable, reverse replacement offers remarkable functional restoration — including a path back to the active Ventura County lifestyle they value.
At our practice, we perform Mako robotic-assisted reverse shoulder replacement — reducing glenoid malposition from 68.6% to 15.3% compared to conventional technique, and providing CT-based 3D planning that optimizes implant positioning before the first incision.
How I Approach the “Too Large to Repair” Decision in My Thousand Oaks & Simi Valley Practice
Every patient referred to me with a “massive” or “irreparable” rotator cuff tear from elsewhere in Ventura County gets the same evaluation: I pull up their MRI on my workstation and review the raw images personally. Not the radiology report. Not a summary. The actual images — assessing Goutallier grade on each involved tendon, retraction stage, tissue quality at the torn edge, acromiohumeral interval, glenohumeral cartilage status, biceps tendon involvement, and subscapularis integrity.
From that assessment, the surgical decision emerges naturally. Here is the framework I use:
- Goutallier Grade 0–1, any tear size, good tissue quality → Primary repair, with biologic patch augmentation if high-risk (large tear, Grade 2 muscle, prior failed repair). This is the category where the “irreparable” verdict is most often wrong.
- Goutallier Grade 2, significant tear, active younger patient → Primary repair with biologic patch augmentation. The augmentation addresses the elevated re-tear risk from the compromised tissue quality.
- Goutallier Grade 3–4, no glenohumeral arthritis, younger active patient → Superior capsular reconstruction or lower trapezius transfer, depending on tear pattern, subscapularis status, and functional demands.
- Goutallier Grade 3–4, older or lower-demand patient, no significant arthritis → Subacromial balloon spacer (InSpace) is a reasonable first-line option if pain relief is the primary goal and active range of motion is preserved.
- Cuff tear arthropathy — humeral head migration, glenohumeral cartilage destruction → Reverse total shoulder replacement. The most reliable, most evidence-supported option at this stage of disease. Mako robotic-assisted at our practice.
Not every patient fits neatly into one category. Some have a complex combination of factors — a partially repairable supraspinatus with a completely irreparable infraspinatus, early cartilage changes but not frank arthropathy, moderate fatty infiltration with excellent tissue quality at the torn edge. These are the cases that require the most surgical judgment — and the cases where fellowship training and case volume matter most.
Why Volume and Subspecialty Focus Matter for These Complex Cases
I want to be direct about something that the research supports unambiguously: the technical complexity of massive rotator cuff tear management — particularly biologic patch augmentation, superior capsular reconstruction, and tendon transfer — is not evenly distributed across orthopedic practices in Ventura County.
These are not procedures that every shoulder surgeon performs. Biologic patch augmentation requires specific graft preparation, precise arthroscopic fixation technique, and intraoperative judgment about graft positioning that comes from repetition. Superior capsular reconstruction is technically demanding enough that outcomes are strongly associated with surgeon experience. Lower trapezius tendon transfer is a procedure that relatively few shoulder surgeons in Southern California perform at meaningful volume.
I perform all of these procedures at our Thousand Oaks and Simi Valley offices — and I perform them at sufficient volume to have developed the technical proficiency and clinical pattern recognition that complex cases demand. For patients from across Ventura County who have been told their tear is irreparable, or who have had a failed repair elsewhere and are considering their next steps, I believe that what I offer in subspecialty expertise and procedural volume is genuinely differentiated from what is available at most practices in this region.
That is not a marketing statement. It is a reflection of the outcomes literature on surgical volume and complexity, applied honestly to the context of what my practice offers versus what most general orthopedic practices in the Conejo Valley can provide for these specific cases.
Frequently Asked Questions
Is my rotator cuff tear really too large to repair?
Not necessarily. Whether a tear is “irreparable” depends on multiple MRI variables — Goutallier muscle grade, tendon retraction stage, tissue quality, and number of tendons involved — that require fellowship-trained review of the raw imaging files, not just the radiology report. Many tears labeled as irreparable by general orthopedic surgeons are repairable by high-volume shoulder subspecialists, sometimes with biologic patch augmentation to reduce re-tear risk. Bring your MRI disc to a consultation at our Thousand Oaks (805-379-4574) or Simi Valley (805-527-1404) offices for an independent assessment.
What is biologic patch augmentation and who needs it?
Biologic patch augmentation involves placing a biological scaffold — typically an acellular dermal allograft — over a primary rotator cuff repair to mechanically reinforce it and reduce re-tear risk. A 2025 meta-analysis of 24 studies including 12 randomized controlled trials found that structural augmentation significantly reduced re-tear rates. Patients most likely to benefit are those with large or massive tears, Grade 2 fatty infiltration, prior failed repairs, or other high-risk features identified on preoperative MRI scoring.
What is superior capsular reconstruction?
Superior capsular reconstruction (SCR) is an arthroscopic procedure that reconstructs the superior capsule of the shoulder using a graft — typically a dermal allograft or the long head of the biceps tendon — to restore superior stability of the humeral head when the supraspinatus is irreparably torn. A 2024 meta-analysis of 456 patients found SCR significantly reduced re-tear rates (OR=0.21) compared to conventional repair for large and massive tears. It is best suited for younger, higher-demand patients with irreparable posterosuperior tears and preserved glenohumeral cartilage.
What is the InSpace subacromial balloon spacer?
The InSpace (OrthoSpace/Stryker) is a biodegradable balloon implanted arthroscopically into the subacromial space for patients with massive irreparable rotator cuff tears. It physically separates the humeral head from the acromion, reducing impingement and allowing better arm elevation. FDA-cleared in 2021, it is best suited for older, lower-demand patients (70s–80s) with preserved active range of motion who prioritize a fast recovery with minimal immobilization. A 2024 systematic review of 894 patients found significant improvements in ASES scores at 12 and 24 months.
I had a rotator cuff repair that failed. What are my options?
Failed rotator cuff repair is one of the most common reasons patients seek a second opinion at our Thousand Oaks and Simi Valley offices. Options depend on the reason for failure, remaining tissue quality, and Goutallier grade — which is often worse after a failed repair than it was at the time of the original surgery. Biologic patch augmentation for revision repair, SCR, tendon transfer, or reverse shoulder replacement are all possible depending on the specific findings on your current MRI. Bring your original operative report, all imaging, and any implant records to your consultation.
Is biologic patch augmentation available in Thousand Oaks or Simi Valley?
Yes. Dr. Lucky Sivasundaram performs biologic patch augmentation for rotator cuff repair — including acellular dermal allograft and bioinductive collagen patch techniques — at offices in Thousand Oaks (137 E Thousand Oaks Blvd, 805-379-4574) and Simi Valley (2525 Erringer Road, 805-527-1404). He is one of the few surgeons in Ventura County performing this procedure at the volume associated with optimal outcomes in the peer-reviewed literature.
Get a Second Opinion on Your “Irreparable” Rotator Cuff Tear — Thousand Oaks & Simi Valley
If you’ve been told your rotator cuff tear is too large to repair, or if a prior repair has failed, bring your MRI disc and your questions to our office. The options available in 2025 — biologic patch augmentation, superior capsular reconstruction, lower trapezius transfer, InSpace balloon spacer, and Mako robotic-assisted reverse shoulder replacement — mean that “irreparable” is rarely the end of the conversation. Serving Thousand Oaks, Simi Valley, Westlake Village, Moorpark, Camarillo, Oxnard, and throughout Ventura County.
Thousand Oaks, CA 91360
(805) 379-4574
Mon–Fri 8am–5pm
Simi Valley, CA 93065
(805) 527-1404
Mon–Fri 8:30am–5pm
References
- Kim YS, et al. Patch Augmentation Using Acellular Dermal Matrix During Arthroscopic Rotator Cuff Repair Reduces Retear Rates in High-Risk Patients With Rotator Cuff Healing Index 7 or Higher. Arthroscopy. Published April 28, 2026. doi:10.1002/arj.70187
- Systematic Review. Structural Augmentation in Rotator Cuff Repair Decreases the Risk of Retear: A Systematic Review and Meta-analysis. 24 studies including 12 RCTs. Published January 2026. ResearchGate.
- Weiss A, et al. Rotator cuff repair augmentation: a review of current techniques. Annals of Joint. 2025. doi:10.21037/aoj-24-53
- JSES. Bioinductive patch as an augmentation for rotator cuff repair — systematic review and meta-analysis. Overall retear rate 8.3% full-thickness. Journal of Shoulder and Elbow Surgery. 2024. doi:10.1016/j.jse.2024.04.004
- Shin K-H, Jang I-T, Han S-B. Outcomes of Superior Capsular Reconstruction Using the Long Head of the Biceps Tendon in Large to Massive Rotator Cuff Tears: A Meta-Analysis and Systematic Review. Journal of Clinical Medicine. 2024;13(4):1052. PMC10889218.
- Ganokroj P, Whalen RJ, Provencher MT. Superior Capsular Reconstruction for Massive Rotator Cuff Tear. Arthroscopy. March 2024.
- McKissack HM, Cooke HL, et al. Arthroscopic-Assisted Lower Trapezius Transfer Versus Superior Capsular Reconstruction for Treatment of Massive Irreparable Rotator Cuff Tears. Journal of Shoulder and Elbow Surgery. June 2025.
- Sirignano P, et al. Subacromial balloon spacer massive rotator cuff tear treatment systematic review and meta-analysis: 27 studies, 894 patients. Knee Surgery, Sports Traumatology, Arthroscopy. 2024. doi:10.1002/ksa.12331
- Arthroscopy Journal. Subacromial Balloon Spacer for Massive Rotator Cuff Tears — Improved Shoulder Functionality and High Revision-Free Survival at Minimum 5-Year Follow-Up. 2025.
- Verma N, et al. InSpace implant compared with partial repair for massive rotator cuff tears: SPACE trial multicenter RCT. Journal of Bone and Joint Surgery. 2022;104(14):1250–1262.
- Darbandi A, et al. Fatty infiltration, tear size, and retraction size are significant risk factors for retear after arthroscopic rotator cuff repair: A systematic review. Arthroscopy. 2025;41:1649–1666.


